Bill Information > HB 2710
Search for another bill or initiative:
HB 2710 - 2019-20
Modifying the uses, disclosure, and requirement dates of prescription drug price transparency data.
Bill History
2020 REGULAR SESSION
IN THE HOUSE
Jan 20
First reading, referred to Health Care & Wellness.
(View Original Bill)
Jan 29
Public hearing in the House Committee on Health Care & Wellness at 1:30 PM.
(Committee Materials)
Feb 4
Executive action taken in the House Committee on Health Care & Wellness at 1:30 PM.
(Committee Materials)
HCW - Majority; do pass.
(Majority Report)
Feb 6
Referred to Rules 2 Review.
Feb 16
Rules Committee relieved of further consideration. Placed on second reading.
Feb 17
Rules suspended. Placed on Third Reading.
Third reading, passed; yeas, 56; nays, 42; absent, 0; excused, 0.
(View Roll Calls)
IN THE SENATE
Feb 19
First reading, referred to Health & Long Term Care.
Feb 28
Public hearing and executive session scheduled, but no action was taken in the Senate Committee on Health & Long Term Care at 8:00 AM.
(Committee Materials)
Mar 12
By resolution, returned to House Rules Committee for third reading.
Available Documents
For a complete list of documents, go to Online Reports Text of a Legislative Document.
Fiscal Note
Amendments
Available Videos